This project, the primary target users are patients with cancer stages 3 and above. Cancer patients who are seeking out to have a painless treatment. While the secondary target users are Clinicians who wishes to refer our website. 

This website is also designed for responsive design (able to view across all devices such as: desktop, laptop, iPad and mobile phones.

*Please note that the information above might change without my prior notice. For the latest information please view the respective web link below:

http://asia-genomics.com/services/intermountain-icg-100/

http://asia-genomics.com/services/guardant360/